Related Experiment Video
Updated: Jul 3, 2025

Peptide-based Identification of Functional Motifs and their Binding Partners
Published on: June 30, 2013
HIV, HIV-Specific Factors, and Myocardial Disease in Women
Yoko Kato1, Bharath Ambale-Venkatesh2, Mahim Naveed3,4
1Division of Cardiology, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Insights
Women with HIV on antiretroviral therapy show increased heart inflammation and fibrosis, especially with unsuppressed viral load or low CD4 counts. This highlights the need for better adherence strategies to prevent cardiac damage.
Area of Science:
- Cardiology
- Infectious Diseases
- Medical Imaging
Background:
- People with human immunodeficiency virus (HIV) have higher cardiovascular disease (CVD) risk.
- Cardiac magnetic resonance (CMR) shows increased myocardial fibrosis, inflammation, and steatosis in people with HIV (PWH).
- Previous studies often used healthy volunteers and focused on men, limiting understanding in women.
Purpose of the Study:
- To investigate associations between HIV and specific factors with CMR-derived cardiac phenotypes in women.
- To assess myocardial fibro-inflammation, fibrosis, and steatosis in women with HIV (WWH).
Main Methods:
- Utilized data from the Women's Interagency HIV Study.
- Assessed myocardial native T1 (fibro-inflammation), extracellular volume fraction (fibrosis), and triglyceride content (steatosis) via CMR.
- Employed multivariable linear regression and meta-analysis to evaluate associations.
Main Results:
- Women with HIV exhibited higher myocardial native T1 (fibro-inflammation) compared to women without HIV.
- Higher native T1 was more pronounced with viremia or low nadir CD4+ counts.
- Low CD4+ counts were also linked to increased extracellular volume fraction (fibrosis); less steatosis was observed in WWH with low CD4+ counts.
Conclusions:
- Women with HIV on antiretroviral therapy (ART) demonstrate elevated myocardial fibro-inflammation compared to HIV-negative women.
- This fibro-inflammation is exacerbated by unsuppressed viremia or CD4+ lymphopenia.
- Findings underscore the need for improved ART adherence and understanding of latent infection to reduce cardiac end-organ damage.
Background:
People with human immunodeficiency virus (HIV) (PWH) have an increased risk of cardiovascular disease (CVD). Cardiac magnetic resonance (CMR) has documented higher myocardial fibrosis, inflammation, and steatosis in PWH, but studies have mostly relied on healthy volunteers as comparators and focused on men.
Methods:
We investigated the associations of HIV and HIV-specific factors with CMR phenotypes in female participants enrolled in the Women's Interagency HIV Study's New York and San Francisco sites. Primary phenotypes included myocardial native (n) T1 (fibro-inflammation), extracellular volume fraction (fibrosis), and triglyceride content (steatosis). Associations were evaluated with multivariable linear regression, and results pooled or meta-analyzed across centers.
Results:
Among 261 women with HIV (WWH, N = 362), 76.2% had undetectable viremia at CMR. For the 82.8% receiving continuous antiretroviral therapy (ART) in the preceding 5 years, adherence was 51.7%, and 69.4% failed to achieve persistent viral suppression (40.7% with peak viral load <200 cp/mL). Overall, WWH showed higher nT1 than women without HIV after full adjustment. This higher nT1 was more pronounced in those with antecedent or current viremia or nadir CD4+ count <200 cells/μL, with the latter also associated with higher extracellular volume fraction. WWH and current CD4+ count <200 cells/μL had less cardiomyocyte steatosis. Cumulative exposure to specific ART showed no associations.
Conclusions:
Compared with sociodemographically similar women without HIV, WWH on ART exhibit higher myocardial fibro-inflammation, which is more prominent with unsuppressed viremia or CD4+ lymphopenia. These findings support the importance of improved ART adherence strategies, along with better understanding of latent infection, to mitigate cardiac end-organ damage in this population.
Related Concept Videos
Sexually Transmitted Infections
Pathophysiology of Heart Failure
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...

